These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 35887351)

  • 1. Patients Recovering from Severe COVID-19 Develop a Polyfunctional Antigen-Specific CD4+ T Cell Response.
    Paolini A; Borella R; Neroni A; Lo Tartaro D; Mattioli M; Fidanza L; Di Nella A; Santacroce E; Gozzi L; Busani S; Trenti T; Meschiari M; Guaraldi G; Girardis M; Mussini C; Gibellini L; De Biasi S; Cossarizza A
    Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35887351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detailed characterization of SARS-CoV-2-specific T and B cells after infection or heterologous vaccination.
    Lo Tartaro D; Paolini A; Mattioli M; Swatler J; Neroni A; Borella R; Santacroce E; Di Nella A; Gozzi L; Busani S; Cuccorese M; Trenti T; Meschiari M; Guaraldi G; Girardis M; Mussini C; Piwocka K; Gibellini L; Cossarizza A; De Biasi S
    Front Immunol; 2023; 14():1123724. PubMed ID: 36845156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High Frequencies of Functional Virus-Specific CD4
    Mele D; Calastri A; Maiorano E; Cerino A; Sachs M; Oliviero B; Mantovani S; Baldanti F; Bruno R; Benazzo M; Grifoni A; Sette A; Mondelli MU; Varchetta S
    Front Immunol; 2021; 12():748881. PubMed ID: 34858405
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Manufacture and Characterization of Good Manufacturing Practice-Compliant SARS-COV-2 Cytotoxic T Lymphocytes.
    Chu Y; Milner J; Lamb M; Maryamchik E; Rigot O; Ayello J; Harrison L; Shaw R; Behbehani GK; Mardis ER; Miller K; Prakruthi Rao Venkata L; Chang H; Lee D; Rosenthal E; Kadauke S; Bunin N; Talano JA; Johnson B; Wang Y; Cairo MS
    J Infect Dis; 2023 Mar; 227(6):788-799. PubMed ID: 36583990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IFN-γ
    Vallejo A; Vizcarra P; Quereda C; Moreno A; Casado JL;
    Eur J Clin Invest; 2021 Dec; 51(12):e13636. PubMed ID: 34164811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of IFNγ-Secreting CD4
    Matyushenko V; Isakova-Sivak I; Kudryavtsev I; Goshina A; Chistyakova A; Stepanova E; Prokopenko P; Sychev I; Rudenko L
    Viruses; 2021 Jul; 13(8):. PubMed ID: 34452355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mild Cytokine Elevation, Moderate CD4
    Jia R; Wang X; Liu P; Liang X; Ge Y; Tian H; Chang H; Zhou H; Zeng M; Xu J
    Virol Sin; 2020 Dec; 35(6):734-743. PubMed ID: 32699972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SARS-CoV-2-reactive interferon-γ-producing CD8+ T cells in patients hospitalized with coronavirus disease 2019.
    Giménez E; Albert E; Torres I; Remigia MJ; Alcaraz MJ; Galindo MJ; Blasco ML; Solano C; Forner MJ; Redón J; Signes-Costa J; Navarro D
    J Med Virol; 2021 Jan; 93(1):375-382. PubMed ID: 32579268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Helminth antigens differentially modulate the activation of CD4
    Adjobimey T; Meyer J; Terkeš V; Parcina M; Hoerauf A
    BMC Med; 2022 Jun; 20(1):241. PubMed ID: 35764965
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD4
    Popescu I; Snyder ME; Iasella CJ; Hannan SJ; Koshy R; Burke R; Das A; Brown MJ; Lyons EJ; Lieber SC; Chen X; Sembrat JC; Bhatt P; Deng E; An X; Linstrum K; Kitsios G; Konstantinidis I; Saul M; Kass DJ; Alder JK; Chen BB; Lendermon EA; Kilaru S; Johnson B; Pilewski JM; Kiss JE; Wells AH; Morris A; McVerry BJ; McMahon DK; Triulzi DJ; Chen K; Sanchez PG; McDyer JF
    Am J Respir Crit Care Med; 2022 Jun; 205(12):1403-1418. PubMed ID: 35348444
    [No Abstract]   [Full Text] [Related]  

  • 11. The effect of age on the magnitude and longevity of Th1-directed CD4 T-cell responses to SARS-CoV-2.
    Nattrass RG; Krafft L; Zjablovskaja P; Schuster M; Kasmapour B; Sarisoy C; Minich J; Bach E; Streeck H
    Immunology; 2022 Jul; 166(3):327-340. PubMed ID: 35396852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinct Expression Patterns of Interleukin-22 Receptor 1 on Blood Hematopoietic Cells in SARS-CoV-2 Infection.
    Albayrak N; Orte Cano C; Karimi S; Dogahe D; Van Praet A; Godefroid A; Del Marmol V; Grimaldi D; Bondue B; Van Vooren JP; Mascart F; Corbière V
    Front Immunol; 2022; 13():769839. PubMed ID: 35422799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Performance comparison of a flow cytometry immunoassay for intracellular cytokine staining and the QuantiFERON® SARS-CoV-2 test for detection and quantification of SARS-CoV-2-Spike-reactive-IFN-γ-producing T cells after COVID-19 vaccination.
    Tormo N; Giménez E; Martínez-Navarro M; Albert E; Navalpotro D; Torres I; Gimeno C; Navarro D
    Eur J Clin Microbiol Infect Dis; 2022 Apr; 41(4):657-662. PubMed ID: 35165804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potent SARS-CoV-2-Specific T Cell Immunity and Low Anaphylatoxin Levels Correlate With Mild Disease Progression in COVID-19 Patients.
    Lafon E; Diem G; Witting C; Zaderer V; Bellmann-Weiler RM; Reindl M; Bauer A; Griesmacher A; Fux V; Hoermann G; Miller C; Zabernigg A; Wöll E; Wilflingseder D; Lass-Flörl C; Posch W
    Front Immunol; 2021; 12():684014. PubMed ID: 34194438
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the Levels of Peripheral CD3
    Aljabr W; Al-Amari A; Abbas B; Karkashan A; Alamri S; Alnamnakani M; Al-Qahtani A
    Microbiol Spectr; 2022 Feb; 10(1):e0084521. PubMed ID: 35196808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. COVID-19 patients display changes in lymphocyte subsets with a higher frequency of dysfunctional CD8lo T cells associated with disease severity.
    Onofrio LI; Marin C; Dutto J; Brugo MB; Baigorri RE; Bossio SN; Quiróz JN; Almada L; Ruiz Moreno F; Olivera C; Silvera-Ruiz SM; Ponce NE; Icely PA; Amezcua Vesely MC; Fozzatti L; Rodríguez-Galán MC; Stempin CC; Cervi L; ; Maletto BA; Acosta Rodríguez EV; Bertone M; Abiega CD; Escudero D; Kahn A; Caeiro JP; Maccioni M; Motrán CC; Gruppi A; Sotomayor CE; Chiapello LS; Montes CL
    Front Immunol; 2023; 14():1223730. PubMed ID: 37809093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of Th1 and Th2 cytokines expressing CD4+ and CD8+ T cells in rheumatoid arthritis by flow cytometry.
    Berner B; Akça D; Jung T; Muller GA; Reuss-Borst MA
    J Rheumatol; 2000 May; 27(5):1128-35. PubMed ID: 10813277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined assessment of S- and N-specific IL-2 and IL-13 secretion and CD69 neo-expression for discrimination of post-infection and post-vaccination cellular SARS-CoV-2-specific immune response.
    Kratzer B; Schlax LC; Gattinger P; Waidhofer-Söllner P; Trapin D; Tauber PA; Sehgal ANA; Körmöczi U; Rottal A; Feichter M; Oberhofer T; Grabmeier-Pfistershammer K; Borochova K; Dorofeeva Y; Tulaeva I; Weber M; Mühl B; Kropfmüller A; Negrin B; Kundi M; Valenta R; Pickl WF
    Allergy; 2022 Nov; 77(11):3408-3425. PubMed ID: 35690994
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Off-the-Shelf Partial HLA Matching SARS-CoV-2 Antigen Specific T Cell Therapy: A New Possibility for COVID-19 Treatment.
    Kim N; Lee JM; Oh EJ; Jekarl DW; Lee DG; Im KI; Cho SG
    Front Immunol; 2021; 12():751869. PubMed ID: 35003063
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune Response to SARS-CoV-2 Vaccine in 2 Men.
    Gupta S; Su H; Agrawal S
    Int Arch Allergy Immunol; 2022; 183(3):350-359. PubMed ID: 34794147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.